Jpmorgan Chase & CO Outset Medical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Outset Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,073,669 shares of OM stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,073,669
Previous 3,114,700
1.32%
Holding current value
$1.87 Million
Previous $6.91 Million
71.15%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OM
# of Institutions
122Shares Held
37.8MCall Options Held
65.1KPut Options Held
91.3K-
Ameriprise Financial Inc Minneapolis, MN5.2MShares$3.17 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.82MShares$2.33 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$1.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.94MShares$1.19 Million0.0% of portfolio
-
Massachusetts Financial Services CO Boston, MA1.54MShares$938,7030.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $29.3M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...